bendamustine hydrochloride has been researched along with Pneumonia, Pneumocystis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abi Hatem, N; Dameron, M; Gupta, N; Horowitz, M | 1 |
| Barreto, JN; Limper, AH; Mara, KC; Rice, ML; Thompson, CA; Tosh, PK | 1 |
| Bagot, M; Battistella, M; Bouaziz, JD; Brice, P; de Masson, A; Delyon, J; Dumont, M; Herms, F; Lebbé, C; Madelaine, I; Moins-Teisserenc, H; Peffault de Latour, R; Ram-Wolff, C; Roelens, M | 1 |
| Barr, PM; Bernstein, SH; Carter, SJ; Friedberg, JW | 1 |
| Alam, S; Layman, R; Lustberg, M; Reinbolt, RE; Shapiro, C | 1 |
| Höffken, K; Klippstein, A; Sayer, HG; Schneider, CP | 1 |
6 other study(ies) available for bendamustine hydrochloride and Pneumonia, Pneumocystis
| Article | Year |
|---|---|
When to consider Pneumocystis jirovecii prophylaxis in HIV-negative patients.
Topics: Aged; Anti-Bacterial Agents; Bendamustine Hydrochloride; HIV Seronegativity; Humans; Immunocompromised Host; Lung Diseases, Interstitial; Lymphoma, Mantle-Cell; Male; Opportunistic Infections; Pneumonia, Pneumocystis; Prednisone; Pulmonary Disease, Chronic Obstructive; Pulmonary Fibrosis; Rituximab; Trimethoprim, Sulfamethoxazole Drug Combination | 2021 |
Incidence of Pneumocystis jirovecii pneumonia utilizing a polymerase chain reaction-based diagnosis in patients receiving bendamustine.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Immunological; Bendamustine Hydrochloride; Female; Humans; Incidence; Lymphoma, Follicular; Male; Middle Aged; Pneumocystis carinii; Pneumonia, Pneumocystis; Polymerase Chain Reaction; Proportional Hazards Models; Retrospective Studies; Rituximab; Time Factors; Young Adult | 2021 |
Efficacy and safety of brentuximab vedotin plus bendamustine in advanced-stage primary cutaneous T-cell lymphomas.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Brentuximab Vedotin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Pneumonia, Pneumocystis; Severity of Illness Index; Skin; Skin Neoplasms; Treatment Outcome | 2019 |
Pneumocystis jirovecii pneumonia as a complication of bendamustine in a patient receiving bendamustine plus rituximab for marginal zone lymphoma.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Nitrogen Mustard Compounds; Pneumocystis carinii; Pneumonia, Pneumocystis; Rituximab; Treatment Outcome | 2011 |
Pneumocystis jiroveci Pneumonia in an Atypical Host.
Topics: Adrenal Cortex Hormones; Anti-Infective Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bevacizumab; Breast Neoplasms; CD4 Lymphocyte Count; Clinical Trials, Phase I as Topic; Dexamethasone; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Nitrogen Mustard Compounds; Paclitaxel; Pneumocystis carinii; Pneumonia, Pneumocystis; Quinazolines; Trimethoprim, Sulfamethoxazole Drug Combination | 2012 |
Pneumocystis carinii pneumonia as a complication of bendamustine monotherapy in a patient with advanced progressive breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Administration Schedule; Fatal Outcome; Female; Humans; Leukopenia; Middle Aged; Nitrogen Mustard Compounds; Pneumonia, Pneumocystis; Respiratory Insufficiency; Treatment Failure | 2003 |